Please use this identifier to cite or link to this item: https://doi.org/10.1080/17425255.2018.1541347
DC FieldValue
dc.titleCDK4-6 inhibitors in breast cancer: current status and future development
dc.contributor.authorJoan Choo
dc.contributor.authorSoo-Chin Lee
dc.date.accessioned2018-12-18T03:32:59Z
dc.date.available2018-12-18T03:32:59Z
dc.date.issued2018-11-03
dc.identifier.citationJoan Choo, Soo-Chin Lee (2018-11-03). CDK4-6 inhibitors in breast cancer: current status and future development. Expert Opinion on Drug Metabolism & Toxicology 11 (14) : 1123-1138. ScholarBank@NUS Repository. https://doi.org/10.1080/17425255.2018.1541347
dc.identifier.issn1742-5255
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/149940
dc.publisherTaylor & Francis
dc.typeReview
dc.contributor.departmentMEDICINE
dc.description.doi10.1080/17425255.2018.1541347
dc.description.sourcetitleExpert Opinion on Drug Metabolism & Toxicology
dc.description.volume11
dc.description.issue14
dc.description.page1123-1138
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108017425255.2018.1541347.zip2 MBZIP

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.